亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Noncardiac Surgery: Some Care During Mechanical Circulatory Support Should Not Be Shared

医学 心室辅助装置 植入 心力衰竭 急诊医学 循环系统 重症监护医学 内科学 外科
作者
Jennifer Cowger
出处
期刊:Asaio Journal [Lippincott Williams & Wilkins]
卷期号:62 (4): 361-363
标识
DOI:10.1097/mat.0000000000000389
摘要

Within the past 5 years, the number of durable mechanical circulatory support (MCS) implants for management of end-stage systolic heart failure within the United States has over doubled—from 1,000 devices per year in 2009 to over 2,500 implants in 2014.1 With a median survival of 4 years after MCS implant, the overall prevalence of patients living on MCS within the community is steadily increasing.1 Freedom from first readmission is only 30% at 1 year after device implant,1 and more and more hospitals and emergency rooms are encountering (often unexpectedly) patients on MCS with device related and device unrelated medical and surgical maladies. Yet, the numbers of medical professionals within the general medical community with training in MCS are few. Thus, one can extrapolate that some hospitalized MCS patients are being cared for by practitioners with little understanding about critical MCS management issues and some MCS patients may even be admitted to hospitals without the obligatory ventricular assist device (VAD) peripherals (e.g., batteries, monitors) necessary for patient monitoring and safe device function. In this issue of ASAIO J, Taghavi et al.2 use the National Inpatient Sample database to better characterize the frequency and types of noncardiac surgeries endured by left ventricular assist device (LVAD) patients during the patient’s index MCS admission, as well as the morbidity and mortality associated with the need for noncardiac surgery (NCS). Of 1,397 patients, 21% required NCS during the index MCS stay, most of which were general surgery or vascular procedures.2 Frequencies of wound infections and bleeding complications were almost double in patients requiring NCS compared with controls.2 While inpatient mortality was not statistically different between NCS (23%) patients and controls (18%, p = 0.10), the mortality trends in MCS patients requiring NCS cannot be ignored (odds ratio [95% confidence interval] = 1.45 [0.95–2.2]) and statistical significance was likely power related.2 All of the patients in the Taghavi et al.2 analysis were being cared for at an MCS implant center, presumably with MCS medical, surgical, and anesthesia specialists on site for consultation regarding device and patient management. Despite this “ideal” specialized care setting, MCS patients still had a high burden of adverse outcomes after NCS. However, there are limitations to extrapolating NCS hazards during the index VAD implant to that of NCS in patients on longer term (e.g., >90 days postop) MCS support. Complications following MCS implant often have fluctuating hazards (Figure 1), with event hazards being highest in the early postoperative period followed by a decline in hazard around postoperative month 3.1 For some adverse events, such as infection, the mortality hazard begins to rise again as support duration increases. For other events, such as stroke, the postoperative hazard holds relatively constant after month 3.1 To date, no study has published hazard trends on the requirement for NCS during long-term MCS support and/or the hazard for mortality following NCS during chronic MCS support.Figure 1.: Hazard function curves for instantaneous risk of death from major adverse events in INTERMACS patients. INTERMACS, interagency registry for mechanically assisted circulatory support; MSOF, multisystem organ failure; RHC, right heart failure. Adapted with permission from Kirklin et al.1 (Figure 10, p. 1499). We can glean some information on overall NCS burden and morbidity during long-term MCS support from published small cohort studies (Table 1).3–9 The requirement for NCS ranges from 23% to 41%, with large variation in cumulative incidence due to study differences in patient follow-up duration and inclusion or exclusion of minor surgical procedures in the numerator. Overall, abdominal and vascular NCS procedures are predominant. Aside from two studies with no deaths, operative mortality ranges 6.4–17% at a mean 38–317 days of patient support time and bleeding and infectious complications are common.2–8 If one follows the ACC/AHA guidelines on cardiac surgical risk, this would classify the average MCS-NCS operation as high risk (>5% risk of death or infarction).10 Importantly, all published studies in Table 1 examined events occurring at MCS implanting centers and there is no data on outcomes when surgery is performed at non-MCS specialty hospitals.2–8 In addition to the high morbidity and mortality discussed herein, MCS specific factors such as vitals (blood pressure, oxygenation) monitoring during nonpulsatile support, driveline avoidance on abdominal cavity entrance and postop driveline care, anticoagulation management, and laboratory and MCS device parameter monitoring complicate the NCS procedure and postoperative management of even lower risk interventions. Thus, it is critical for patients, local emergency rooms, and local hospitals without MCS specialists to understand that unless a patient is too unstable for transfer, MCS patients requiring NCS should be cared for at an MCS specialty hospital.Table 1.: Summary of Cohort Studies Examining Noncardiac Surgery Outcomes After Mechanical Circulatory Support
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
呆萌的鞯完成签到,获得积分10
5秒前
金木zzz完成签到,获得积分10
5秒前
萧雨墨发布了新的文献求助200
9秒前
9秒前
llllu完成签到 ,获得积分10
11秒前
深蓝盾狗_凝神定气做好准备完成签到,获得积分10
13秒前
芬芬完成签到 ,获得积分10
14秒前
21秒前
23秒前
25秒前
喻白完成签到,获得积分10
26秒前
萧雨墨发布了新的文献求助20
28秒前
喻白发布了新的文献求助10
28秒前
36秒前
Jun的应助被喻白采纳,获得10
38秒前
NexusExplorer的应助被LLL采纳,获得10
39秒前
43秒前
45秒前
49秒前
LLL完成签到,获得积分10
50秒前
fantasy的应助被科研通管家采纳,获得10
55秒前
55秒前
科研通AI65的应助被科研通管家采纳,获得10
55秒前
LLL发布了新的文献求助10
56秒前
榨菜完成签到 ,获得积分10
57秒前
CAOHOU的应助被萧雨墨采纳,获得10
1分钟前
1分钟前
yao发布了新的文献求助10
1分钟前
七友完成签到 ,获得积分10
1分钟前
渢薃完成签到,获得积分10
1分钟前
踏实的初晴完成签到 ,获得积分10
1分钟前
1分钟前
充电宝的应助被白华苍松采纳,获得10
1分钟前
科研通AI6.3的应助被萧雨墨采纳,获得10
1分钟前
1分钟前
张宝完成签到,获得积分10
1分钟前
1分钟前
1分钟前
科研通AI65的应助被萧雨墨采纳,获得10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190075
求助须知:如何正确求助?哪些是违规求助? 9577196
关于积分的说明 21851952
捐赠科研通 7788182
什么是DOI,文献DOI怎么找? 3436234
关于科研通互助平台的介绍 2559936
邀请新用户注册赠送积分活动 2482810